| Control Practices | Intervention Practices |  | ||
---|---|---|---|---|---|
Measures | Baseline | Follow-up | Baseline | Follow-up | Â |
Attendance | Â | Â | Â | Â | Odds Ratio (95% CI) |
Proportion of patients with at least one appointment | 73.4% | 67.7% | 74.3% | 81.7% | 2.00* (1.02, 3.91) |
Mean number of appointments | 1.23 | 1.35 | 1.29 | 2.02 | Relative Risk 1.26 (0.87, 1.81) |
Process of care | Â | Â | Â | Â | Â |
Fundoscopy recorded | 49.5% | 50.5% | 43.1% | 60.6% | 1.45 (0.88, 2.40) |
Feet examination recorded | 46.1% | 48.8% | 48.0% | 67.3% | 1.87*(1.09, 3.21) |
Dietary advice recorded | 19.9% | 29.2% | 25.3% | 46.3% | 2.77*(1.22, 6.29) |
Smoking status recorded | 34.2% | 48.0% | 36.9% | 66.0% | 2.43*(1.18, 5.00) |
Was subject a smoker? | 19.3% | 19.6% | 20.7% | 21.4% | 0.72 (0.38, 1.37) |
BP recorded | 59.3% | 48.3% | 55.3% | 71.4% | 2.14*(1.06, 4.36) |
HbA1c recorded | 64.0% | 66.0% | 60.9% | 79.0% | 1.58 (0.81, 3.08) |
Cholesterol recorded | 57.0% | 61.1% | 53.3% | 78.0% | 1.66 (0.89, 3.12) |
Creatinine recorded | 48.0% | 60.4% | 53.0% | 73.4% | 1.36 (0.72, 2.52) |
Albumin:creatinine ratio recorded | 26.8% | 29.7% | 30.2% | 40.4% | 1.60(0.98, 2.60) |
Clinical | Â | Â | Â | Â | Difference |
Mean most recent systolic blood pressure | 144.5 | 144.6 | 145.8 | 144.2 | -1.56 (-4.54, 1.42) |
Mean most recent diastolic blood pressure | 80.2 | 78.1 | 79.2 | 77.8 | -0.40 (-1.78, 0.97) |
Mean most recent HbA1c# | 7.56 | 7.35 | 7.75 | 7.32 | -0.04 (-0.18, 0.10) |
Mean most recent cholesterol# | 5.27 | 5.06 | 5.23 | 4.94 | -0.15**(-0.25, -0.06) |
Mean most recent creatinine# | 93.1 | 96.1 | 91.8 | 95.7 | 0.21 (-1.27, 1.70) |
Mean most recent albumin:creatinine ratio# | 8.99 | 8.45 | 8.48 | 8.05 | -1.6 (-4.4, 1.2) |
Diabetes medication | Â | Â | Â | Â | Relative risk (95% CI) |
Biguanide, Sulphonylurea or Thiazol | 944 (49.0%) | 1128 (58.5%) | 646 (38.9%) | 923 (55.5%) | 1.06 (0.94, 1.19) |
Metformin | 424 (22.0%) | 573 (29.7%)) | 343 (20.6% | 530 (31.9) | 1.07 (0.81, 1.41) |
Insulin | 57 (3.0%) | 75 (3.9%) | 54 (3.2%) | 75 (4.5%) | 1.15 (0.83, 1.58) |
Cardiovascular risk factor drugs | Â | Â | Â | Â | Â |
Aspirin | 10 (0.5%) | 164 (8.5%) | 34 (2.0%) | 308 (18.5%) | 2.08* (1.00, 4.32) |
Ace Inhibitor | 17 (0.9%) | 103 (5.3%) | 31 (1.9%) | 185 (11.1%) | 2.03* (1.08, 3.78) |
ACE inhibitor or Angiotensin-II receptor antagonist | 21 (1.1%) | 109 (5.7%) | 38 (2.3%) | 192 (11.6%) | 1.86* (1.03, 3.38) |
Any antihypertensive | 118 (6.1%) | 274 (14.2%) | 131 (7.9%) | 415 (25.0%) | 1.89*(1.16, 3.08) |
Lipid-lowering | 110 (5.7%) | 290 (15.0%) | 79 (4.8%) | 418 (25.2%) | 1.66 (0.99, 2.79) |
Any medication | 1674 (86.9%) | 1838 (95.4%) | 1283 (77.2%) | 1549 (93.2%) | 1.01 (0.94, 1.08) |